This activity is expired and is no longer available for CME credit.


Nitric Oxide in Glaucoma Management: Get in the kNOw

Author(s)/Faculty: Jason Bacharach, MD; Inder Paul Singh, MD; Sarah H. Van Tassel, MD
Release Date: 4/21/2020Expiration Date: 4/20/2021
Credit Type: CME / ABO MOCNumber of Credits: 0
Content Type: LectureProvider:
Inadequate control of intraocular pressure (IOP) in patients with glaucoma puts many at risk for disease progression and potential impairment of vision-related quality of life. Traditionally, glaucoma therapies have targeted aqueous humor production or aqueous outflow via the unconventional outflow pathway but have done little to restore function of the conventional outflow pathway. Studies have demonstrated that nitric oxide plays a key role in IOP regulation via its action on the conventional outflow pathway and have led to the development of nitric oxide-donating agents for enhanced IOP regulation. In this continuing medical education activity, experts in the field will review and discuss the role of nitric oxide in regulating IOP, the rationale for targeting nitric oxide for glaucoma management, as well as examine the latest clinical evidence regarding the use of nitric oxide-based agents for the management of patients with glaucoma.